Advertisement

Infective Endocarditis

Chapter
  • 724 Downloads
Part of the Contemporary Cardiology book series (CONCARD)

Abstract

The diagnosis of infective endocarditis must be considered and excluded in all individuals with a heart murmur and fever of unknown origin. Infection of the heart valves is caused by bacteria and, rarely by Coxiella, or Chlamydia; fungi are causative in approximately 1%.

Keywords

Kawasaki Disease Infective Endocarditis Bicuspid Aortic Valve Mitral Valve Prolapse Prosthetic Heart Valve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Bibliography

  1. 1.
    Alexiou C, Langley SM, Stafford H, et al. Surgery for active culture-positive endocarditis: determinants of early and late outcome. Ann Thorac Surg 2000;69:1448–1451.PubMedCrossRefGoogle Scholar
  2. 2.
    Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its complications. Circulation 1998;98:2936–2948.PubMedGoogle Scholar
  3. 3.
    Bayer AS, Scheld WM. Endocarditis and intravascular infection. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, fifth edition. Philadelphia, PA: Churchill Livingston; 2000, pp. 857–902.Google Scholar
  4. 4.
    Cabell CH, Abrutyn E, Karchmer AW. Cardiology patient page. Bacterial endocarditis: the disease, treatment, and prevention. Circulation 2003;107:e185–e187.PubMedGoogle Scholar
  5. 5.
    Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794–1801.PubMedCrossRefGoogle Scholar
  6. 6.
    De Castro S, Magni G, Beni S, et al. Role of transthoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am J Cardiol 1997;80:1030–1034.PubMedCrossRefGoogle Scholar
  7. 7.
    Devereux RB, Frary CJ, Kramer-Fox R, et al. Cost-effectiveness of infective endocarditis prophylaxis for mitral valve prolapse with or without a mitral regurgitant murmur. Am J Cardiol 1994;74:1024.PubMedCrossRefGoogle Scholar
  8. 8.
    Durack DT. Prevention of infective endocarditis. N Engl J Med 1995;332:38.PubMedCrossRefGoogle Scholar
  9. 9.
    Ferrieri P, Gewitz MH, Gerber MA, et al., from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the American Heart Association Council on Cardiovascular Disease in the Young. Unique features of infective endocarditis in childhood. Circulation 2002;105:2115–2126.PubMedCrossRefGoogle Scholar
  10. 10.
    Granowitz EV, Longworth DL. Stratification and bedside prognostication in infective endocarditis. JAMA 2003;289:1991–1993.PubMedCrossRefGoogle Scholar
  11. 11.
    Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA 2003;289:1933–1940.PubMedCrossRefGoogle Scholar
  12. 12.
    Hayek E, Gring CN, Griffin BP. Mitral valve prolapse. Lancet 2005;365:507–518.PubMedGoogle Scholar
  13. 13.
    Jault F, Gandjbakhch I, Rama A, et al. Active native valve endocarditis: determinants of operative death and late mortality. Ann Thorac Surg 1997;63:1737–1741.PubMedCrossRefGoogle Scholar
  14. 14.
    Lavie CJ, Khandheria BK, Seward JB, Tajik AJ, Taylor CL, Ballard DJ. Factors associated with the recommendation for endocarditis prophylaxis in mitral value prolapse. JAMA 1989;262:3308–3312.PubMedCrossRefGoogle Scholar
  15. 15.
    Lewin MB, Otto CM. The bicuspid aortic valve: adverse outcomes from infancy to old age. Circulation 2005;111:832–834.PubMedCrossRefGoogle Scholar
  16. 16.
    Moreillon P, Que YA. Infective endocarditis. Lancet 2004;363:139–149.PubMedCrossRefGoogle Scholar
  17. 17.
    Spirito P, Rapezzi C, Bellone P, et al. Infective endocarditis in hypertrophic cardiomyopathy: prevalence, incidence, and indications for antibiotic prophylaxis. Circulation 1999;99:2132–2137.PubMedGoogle Scholar
  18. 18.
    Strom BL, Abrutyn E, Berlin JA, et al. Dental and cardiac risk factors for infective endocarditis. Ann Intern Med 1998;129:761–769.PubMedGoogle Scholar
  19. 19.
    Strom BL, Abrutyn E, Berlin JA, et al. Risk factors for infective endocarditis: oral hygiene and nondental exposures. Circulation 2000;102:2842–2848.PubMedGoogle Scholar
  20. 20.
    Tischler MD, Vaitkus PT. The ability of vegetation size on echocardiography to predict clinical complications. J Am Soc Echocardiogr 1997;10:562–568.PubMedCrossRefGoogle Scholar
  21. 21.
    Wilson WR, Karchmer AW, Bisno AL, et al. Antibiotic treatment of adults with infective endocarditis due to viridans streptococci, enterococci, other streptococci, staphylococci, and HACEK microorganisms. JAMA 1995;274:1706–1713.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc., Totowa, NJ 2005

Personalised recommendations